RxDoctor Payments Data

Mark Featherston, MD

Family Medicine · Greensboro, NCNPI 1073572533

Payments from drug & device makers

$1,044in general payments, 2019–2025

Across 34 payments — averaging $30.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Progenacare Global, LLC$362
  • Tactile Systems Technology Inc$231
  • Medtronic$201
  • Boston Scientific$138
  • Organogenesis Inc.$54
  • Biocompatibles, Inc.$17
  • plus $40 from 3 others

What the payments were for

  • Food & beverage$1,044100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Progenacare Global, LLC2$362
Tactile Systems Technology Inc9$231
Medtronic(2 entities)14$201
Boston Scientific3$138
Organogenesis Inc.2$54
Biocompatibles, Inc.1$17
Cashflow Solutions, LLC1$14
Bard Peripheral Vascular, Inc.1$14
GE HealthCare1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,044 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$170,060
Medicare patients
110
Services billed
745

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban24$15,578

Paid to pharmacies, not to this prescriber.

Other family medicine in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →